| Cvs Pharmacy #01254 | |
| 984 Worcester St, Wellesley, Massachusetts 02482 | |
| (781) 235-3555 |
| Name | Cvs Pharmacy #01254 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 984 Worcester St, Wellesley, Massachusetts 02482 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (781) 235-3555 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Adding to previous evidence, a study based on a statewide cancer database shows no increase in cancer risk in patients undergoing spinal fusion surgery with the bone-promoting growth factor recombinant human bone morphogenetic protein (rhBMP). The study appears in Spine, published by Wolters Kluwer.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
Bavarian Nordic has announced that it has received the requirements from the U.S. government's Department of Health and Services (HHS), for the purchase of 20 million doses of an MVA-based smallpox vaccine.
Eminent UK reproductive and genetics experts have become the first in the world licensed to provide a revolutionary IVF procedure using donor DNA – which they spent decades developing – enabling women carrying potentially fatal mitochondrial disease to have healthy, genetically-related babies.
› Verified 4 days ago
| NPI Number | 1174940365 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY #01254 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 984 Worcester St., Wellesley, MA 02482 |
| Phone Number | 781-235-3555 |
News Archive
Adding to previous evidence, a study based on a statewide cancer database shows no increase in cancer risk in patients undergoing spinal fusion surgery with the bone-promoting growth factor recombinant human bone morphogenetic protein (rhBMP). The study appears in Spine, published by Wolters Kluwer.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
Bavarian Nordic has announced that it has received the requirements from the U.S. government's Department of Health and Services (HHS), for the purchase of 20 million doses of an MVA-based smallpox vaccine.
Eminent UK reproductive and genetics experts have become the first in the world licensed to provide a revolutionary IVF procedure using donor DNA – which they spent decades developing – enabling women carrying potentially fatal mitochondrial disease to have healthy, genetically-related babies.
› Verified 4 days ago
News Archive
Adding to previous evidence, a study based on a statewide cancer database shows no increase in cancer risk in patients undergoing spinal fusion surgery with the bone-promoting growth factor recombinant human bone morphogenetic protein (rhBMP). The study appears in Spine, published by Wolters Kluwer.
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
Bavarian Nordic has announced that it has received the requirements from the U.S. government's Department of Health and Services (HHS), for the purchase of 20 million doses of an MVA-based smallpox vaccine.
Eminent UK reproductive and genetics experts have become the first in the world licensed to provide a revolutionary IVF procedure using donor DNA – which they spent decades developing – enabling women carrying potentially fatal mitochondrial disease to have healthy, genetically-related babies.
› Verified 4 days ago
Cvs Pharmacy # 08437 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 188 Linden St, Wellesley, Massachusetts 02482 Phone: (781) 235-0219 | |
Cvs Pharmacy #00363 Type: Medicare Supplier Location: 65 Central St, Wellesley, Massachusetts 02482 Phone: (781) 237-2520 | |
Cvs Pharmacy #01254 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 984 Worcester St, Wellesley, Massachusetts 02482 Phone: (781) 235-3555 | |
Cvs Pharmacy #01299 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 25 Washington Street, Wellesley, Massachusetts 02481 Phone: (781) 263-7234 | |
The Postureworks Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 47 River St, Wellesley, Massachusetts 02481 Phone: (781) 431-0900 |